I doubt our resident intellect even understands wh
Post# of 30067
Posted On: 11/23/2014 5:55:45 PM
I doubt our resident intellect even understands what a molecule is, or if given a list could pick out which ones are molecules and which aren't.
If I had a dollar for each time "small molecule" had been posted on the boards over the last few days, I could buy myself an expensive steak and lobster dinner at a fine restaurant, and have enough left over for an enormous tip.
Just because someone wants to try to stimulate increased MANF production in the body doesn't mean they will be able to do so. Even if they are successful, the method may not be sufficient to produce enough of an increase to matter in the treatment of the disease. There may be negative effects from this process as well. There are just too many variables at this point to warrant much concern by shareholders. Of course, those who manage their investment on a daily basis must consider any and all possible outcomes in order to stay on top of their investment. I wonder if Urano's change to "small molecule" research can somehow be blamed on Gerald. We'd better start holding his feet closer to the flame just in case some connection can be dreamed up.
And here's the $64,000 question that no one has ever mentioned... If the body produces MANF and if MANF shows up whenever there is indication of premature cell death, why doesn't the human body simply produce more on its own? Is there perhaps a threshold of increased MANF levels that fail to see a benefit? If so, wouldn't that tend to negate any possible treatment of injecting doses of recombinant MANF than the body can produce on its own? Such a discovery would certainly kill the potential of this protein. Now I've just given Dave something new to worry about and keep him awake at night.
If I had a dollar for each time "small molecule" had been posted on the boards over the last few days, I could buy myself an expensive steak and lobster dinner at a fine restaurant, and have enough left over for an enormous tip.
Just because someone wants to try to stimulate increased MANF production in the body doesn't mean they will be able to do so. Even if they are successful, the method may not be sufficient to produce enough of an increase to matter in the treatment of the disease. There may be negative effects from this process as well. There are just too many variables at this point to warrant much concern by shareholders. Of course, those who manage their investment on a daily basis must consider any and all possible outcomes in order to stay on top of their investment. I wonder if Urano's change to "small molecule" research can somehow be blamed on Gerald. We'd better start holding his feet closer to the flame just in case some connection can be dreamed up.
And here's the $64,000 question that no one has ever mentioned... If the body produces MANF and if MANF shows up whenever there is indication of premature cell death, why doesn't the human body simply produce more on its own? Is there perhaps a threshold of increased MANF levels that fail to see a benefit? If so, wouldn't that tend to negate any possible treatment of injecting doses of recombinant MANF than the body can produce on its own? Such a discovery would certainly kill the potential of this protein. Now I've just given Dave something new to worry about and keep him awake at night.
(0)
(0)